CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) $ in Thousands	Common Stock	Paid-In Capital	Accumulated Other Comprehensive Loss	Accumulated Deficit	Total
Beginning balance (in shares) at Dec. 31, 2022	237,166,625
Beginning balance at Dec. 31, 2022	$ 2,372	$ 1,259,527	$ (1,040)	$ (655,382)	$ 605,477
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Non-cash stock-based compensation		17,087			$ 17,087
Stock-based awards and related share issuances, net (in shares)	3,333,208
Stock-based awards and related share issuances, net	$ 33	(33)
Repurchase of common stock (in shares)					0
Other comprehensive income			$ 1,040		$ 1,040
Net loss				(66,215)	$ (66,215)
Ending balance (in shares) at Dec. 31, 2023	240,499,833				240,499,833
Ending balance at Dec. 31, 2023	$ 2,405	1,276,581		(721,597)	$ 557,389
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Non-cash stock-based compensation		14,847			14,847
Stock-based awards and related share issuances, net (in shares)	5,784,668
Stock-based awards and related share issuances, net	$ 58	495			$ 553
Repurchase of common stock (in shares)	(7,190,006)				(7,200,000)
Repurchase of common stock	$ (72)	(4,638)			$ (4,710)
Issuance of common stock upon exercise of warrants (in shares)	81,798
Issuance of common stock upon exercise of warrants	$ 1	48			49
Net loss				(78,640)	$ (78,640)
Ending balance (in shares) at Dec. 31, 2024	239,176,293				239,176,293
Ending balance at Dec. 31, 2024	$ 2,392	$ 1,287,333		$ (800,237)	$ 489,488